Retraction
LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression
Paper Information
Record ID:
51801
Author(s):
Journal:
Publication Date:
May 25, 2021
Retraction Date:
January 26, 2024
(1.8 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.2147/OTT.S461191Additional Notes:
see also: https://pubpeer.com/publications/9E6D4FEF3F1B987708EFF99CBB5AFC
Citations (21)
21
Total Citations2
Post-Retraction(9.5%)
19
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
37
Days since retraction (latest)
S100A12 is involved in the pathology of osteoarthritis by promoting M1 macrophage polarization via the NF-κB pathway
Yi Zhang, Zihua Li, Cheng Chen et al. (11 authors)
Connective Tissue Research
Open Access
Published: Mar 2024
2 citations
2 citations
37 days after retraction
The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894
Xiang Zhou, Lisha Chang, Qiaoqiao Liang et al. (7 authors)
Cancer Cell International
Open Access
Published: Jan 2024
20 citations
20 citations
4 days after retraction
Identification of dysregulated miRNAs and their roles in breast cancer; An in silico meta‐analysis study
Davood Ghavi Dorabad, Zahra Foruzandeh, Zahra Torki et al. (6 authors)
Informatics in Medicine Unlocked
Open Access
Published: Dec 2023
2 citations
2 citations
29 days before retraction
Identification of NK cell inhibitory ligand CLEC2D-associating immune infiltration landscape and prognostic value in kidney renal clear cell carcinoma
Cheng Chen, Lan Han, Xiujun Song et al. (4 authors)
Research Square (Research Square)
Open Access
Published: Aug 2023
174 days before retraction
HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies
Sylwia Bartoszewska, Jakub Sławski, James F. Collawn et al. (4 authors)
Cancers
Open Access
Published: May 2023
6 citations
6 citations
246 days before retraction
The M6A Methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894
Xiang Zhou, Leitao Yu, Lihsa Chang et al. (7 authors)
Research Square (Research Square)
Open Access
Published: May 2023
249 days before retraction
Peer Review #1 of "Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma (v0.1)"
Lincheng Ju, Yaxing Shi, Gang Liu
Unknown Journal
Open Access
Published: Dec 2022
403 days before retraction
Peer Review #1 of "Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma (v0.2)"
Lincheng Ju, Yaxing Shi, Gang Liu
Unknown Journal
Open Access
Published: Dec 2022
403 days before retraction
Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
Lincheng Ju, Yaxing Shi, Gang Liu
PeerJ
Open Access
Published: Dec 2022
17 citations
17 citations
403 days before retraction
Peer Review #2 of "Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma (v0.1)"
P Ozretić
Unknown Journal
Open Access
Published: Dec 2022
403 days before retraction
Peer Review #3 of "Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma (v0.1)"
Unknown Authors
Unknown Journal
Open Access
Published: Dec 2022
403 days before retraction
Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation
Xinyu Zhang, Xinyue Qin, Tiannan Yu et al. (6 authors)
Frontiers in Genetics
Open Access
Published: Oct 2022
7 citations
7 citations
463 days before retraction
LincRNAs and snoRNAs in Breast Cancer Cell Metastasis: The Unknown Players
Maria Louca, Vasiliki Gkretsi
Cancers
Open Access
Published: Sep 2022
10 citations
10 citations
494 days before retraction
Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma
Zhenpeng Zhu, Cuijian Zhang, Jinqin Qian et al. (10 authors)
Cancer Cell International
Open Access
Published: Sep 2022
8 citations
8 citations
499 days before retraction
Bioinformatics analysis of the inflammation-associated lncRNA- mRNA co-expression network in type 2 diabetes
Linjuan Huang, Shengxi Xiong, Hanshuang Liu et al. (7 authors)
Research Square (Research Square)
Open Access
Published: Aug 2022
1 citation
1 citation
536 days before retraction
Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression
Bo Chen, Deqing Liu, Runjie Chen et al. (5 authors)
Discover Oncology
Open Access
Published: Jul 2022
16 citations
16 citations
574 days before retraction
Ferroptosis-related lncRNA signature robustly predicts the prognosis and immunotherapy efficiency of clear cell renal cell carcinoma
Lincheng Ju, Yaxing Shi, Gang Liu
Research Square (Research Square)
Open Access
Published: Jun 2022
603 days before retraction
Long Non-Coding RNAs as Novel Biomarkers in the Clinical Management of Papillary Renal Cell Carcinoma Patients: A Promise or a Pledge?
Francesco Trevisani, Matteo Floris, Riccardo Vago et al. (5 authors)
Cells
Open Access
Published: May 2022
11 citations
11 citations
619 days before retraction
RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma
Dong Liu, Mingchen Zhang, Yuanyuan Song et al. (4 authors)
Anti-Cancer Drugs
Published: Mar 2022
5 citations
5 citations
674 days before retraction
Molecular Subtyping and Prognostic Prediction Based on the Ferroptosis-Related Long Non-Coding RNA Signature in Clear Cell Renal Cell Carcinoma
Zhenpeng Zhu, Cuijian Zhang, Jinqin Qian et al. (10 authors)
Research Square (Research Square)
Open Access
Published: Sep 2021
858 days before retraction
A novel <scp>lncRNA‐miRNA‐mRNA</scp> competing endogenous <scp>RNA</scp> regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma
Qiwei Zhou, Diangeng Li, Hongying Zheng et al. (9 authors)
Thoracic Cancer
Open Access
Published: Aug 2021
29 citations
29 citations
881 days before retraction
Quick Stats
Total Citations:
21
Years Since Retraction:
1.8 year
Open Access:
Yes
Last Checked:
Jul 24, 2025